The authors evaluate the present curative indications of anticholinergic and cytoprotector drugs in the treatment of ulcer disease. They conclude that the therapeutic relevance of mucosal protective agents is limited in comparison with the major gastroactive medications especially in the treatment of peptic ulcer disease.